Scholar Rock Holding Corp (SRRK)
15.20
+0.53
(+3.61%)
USD |
NASDAQ |
May 01, 09:39
Scholar Rock Total Assets (Quarterly): 311.04M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 311.04M |
| September 30, 2023 | 250.69M |
| June 30, 2023 | 284.90M |
| March 31, 2023 | 314.72M |
| December 31, 2022 | 358.17M |
| September 30, 2022 | 390.30M |
| June 30, 2022 | 424.13M |
| March 31, 2022 | 265.98M |
| December 31, 2021 | 304.44M |
| September 30, 2021 | 298.39M |
| June 30, 2021 | 332.05M |
| March 31, 2021 | 360.59M |
| December 31, 2020 | 388.30M |
| Date | Value |
|---|---|
| September 30, 2020 | 163.42M |
| June 30, 2020 | 156.36M |
| March 31, 2020 | 175.70M |
| December 31, 2019 | 196.38M |
| September 30, 2019 | 188.54M |
| June 30, 2019 | 196.91M |
| March 31, 2019 | 170.98M |
| December 31, 2018 | 181.34M |
| September 30, 2018 | 109.02M |
| June 30, 2018 | 118.98M |
| March 31, 2018 | 54.16M |
| December 31, 2017 | 61.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
156.36M
Minimum
Jun 2020
424.13M
Maximum
Jun 2022
282.16M
Average
298.39M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 33.08B |
| Ocular Therapeutix Inc | 252.06M |
| Alpine Immune Sciences Inc | 379.85M |
| Keros Therapeutics Inc | 370.02M |
| X4 Pharmaceuticals Inc | 147.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 85.82M |
| Shareholders Equity (Quarterly) | 225.22M |